Literature DB >> 10632418

Use of ethinyl estradiol to reverse the antiestrogenic effects of clomiphene citrate in patients undergoing intrauterine insemination: a comparative, randomized study.

S Gerli1, H Gholami, C Manna, A S Di Frega, C Vitiello, V Unfer, A Manna.   

Abstract

OBJECTIVE: To compare the effectiveness of clomiphene citrate used alone and in combination with ethinyl E2 for the induction of ovulation in patients undergoing IUI.
DESIGN: Randomized, double-blind study.
SETTING: Four infertility treatment centers. PATIENT(S): Women aged 25-35 years with infertility of at least 2 years' duration and oligomenorrhea or amenorrhea associated with a positive menstrual response to an IM progesterone challenge. INTERVENTION(S): A total of 64 patients were randomized to treatment with CC (100 mg daily for 5 days) or CC (100 mg daily for 5 days) plus ethinyl E2 (0.05 mg daily for 5 days). MAIN OUTCOME MEASURE(S): The uterine artery pulsatility index, number of preovulatory follicles, endometrial thickness, and pregnancy rate. RESULT(S): Both treatment regimens increased FSH, LH, and 17beta-E2 levels, with no statistically significant differences. There was a statistically significant difference in endometrial thickness between the two treatment groups. No statistically significant differences were noted in pulsatility index values or in the number of preovulatory follicles. CONCLUSION(S): Ethinyl E2 can reverse the deleterious effects of CC on endometrial thickness, which may contribute to higher pregnancy rates.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10632418     DOI: 10.1016/s0015-0282(99)00447-1

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  15 in total

Review 1.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

Review 2.  A New Dawn for Intrauterine Insemination: Efficient and Prudent Practice will Benefit Patients, the Fertility Industry and the Healthcare Bodies.

Authors:  Gulam Bahadur; Roy Homburg; Ansam Al-Habib
Journal:  J Obstet Gynaecol India       Date:  2016-08-22

Review 3.  Is ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome?

Authors:  S Palomba; F Orio; T Russo; A Falbo; T Cascella; A Colao; G Lombardi; F Zullo
Journal:  J Endocrinol Invest       Date:  2004-09       Impact factor: 4.256

Review 4.  Agents for ovarian stimulation for intrauterine insemination (IUI) in ovulatory women with infertility.

Authors:  Astrid Ep Cantineau; Anouk Gh Rutten; Ben J Cohlen
Journal:  Cochrane Database Syst Rev       Date:  2021-11-05

Review 5.  Oral versus injectable ovulation induction agents for unexplained subfertility.

Authors:  N Athaullah; M Proctor; N P Johnson
Journal:  Cochrane Database Syst Rev       Date:  2002

6.  Comparison of the Effect of Clomiphene- Estradiol Valerate vs Letrozole on Endometrial Thickness, Abortion and Pregnancy Rate in Infertile Women with Polycystic Ovarian Syndrome.

Authors:  Fariba Seyedoshohadaei; Laleh Tangestani; Farnaz Zandvakili; Naser Rashadmanesh
Journal:  J Clin Diagn Res       Date:  2016-08-01

7.  The effect of administering vaginal estrogen to clomiphene citrate stimulated cycles on endometrial thickness and pregnancy rates in unexplained infertility.

Authors:  Kadir Cetinkaya; Sedat Kadanalı
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-09-01

8.  Defining the proliferative phase endometrial defect.

Authors:  Jason G Bromer; Tamir S Aldad; Hugh S Taylor
Journal:  Fertil Steril       Date:  2008-03-07       Impact factor: 7.329

9.  Controlled Ovarian Stimulation Protocols Alter Endometrial Histomorphology and Gene Expression Profiles.

Authors:  John L Wu; Patrick Keller; Mohammed Kanchwala; Chao Xing; Samir N Babayev; Bruce R Carr; Orhan Bukulmez; R Ann Word
Journal:  Reprod Sci       Date:  2020-01-06       Impact factor: 3.060

Review 10.  Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue?

Authors:  Stefano Palomba; Susanna Santagni; Giovanni Battista La Sala
Journal:  J Ovarian Res       Date:  2015-11-19       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.